Use access key #2 to skip to page content.
$31.04 -1.99 (-6.02%)
10/6/2008 4:00 PM

Onyx Pharmaceuticals, Inc. (ONXX)

CAPS Rating:
***

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

View All Commentary (ONXX)

Recs

0

Avatar SierraBlue (67.67) Submitted: 7/08/08 9:11 PM : Outperform Start Price: $39.14 ONXX Score: 5.43

Major drugs Biotechnology

Report this Post Replies: 0 | Reply

Featured Broker Partners